Effects of High-Dose and Conventional-Dose Adjuvant Chemotherapy on Long-Term Cognitive Sequelae in Patients with Breast Cancer: An Electrophysiologic Study-Reference-Cited by-同舟云学术

Effects of High-Dose and Conventional-Dose Adjuvant Chemotherapy on Long-Term Cognitive Sequelae in Patients with Breast Cancer: An Electrophysiologic Study

Published:2006-04 Issue:1 Volume:7 Page:67-78
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Kreukels Baudewijntje P.C.,Schagen Sanne B.,Ridderinkhof K. Richard,Boogerd Willem,Hamburger Hans L.,Muller Martin J.,van Dam Frits S.A.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma;Ahles;J Clin Oncol,2002

2. Cognitive function in breast cancer patients receiving adjuvant chemotherapy;Brezden;J Clin Oncol,2000

3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen;Castellon;J Clin Exp Neuropsychol,2004

4. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer;Tchen;J Clin Oncol,2003

5. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial;Wefel;Cancer,2004

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Breast Cancer Treatment on Neural Noise: a Longitudinal Design;Archives of Clinical Neuropsychology;2024-08-29

2. Neuropsychological manifestations of chemotherapy;Neuropsychological and Psychosocial Foundations of Neuro-Oncology;2024

3. Prevalence of Cognitive Impairment in Patients Receiving 5- Fu Containing Chemotherapy- a Systematic Review and Meta-analysis;2023-11-01

4. Longitudinal Effects of Breast Cancer Treatment on Neural Correlates of Attention;Archives of Clinical Neuropsychology;2022-07-29

5. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions;Drug Safety;2022-05-23